Insights from 2024 WCLC
Playback speed
10 seconds
WCLC 2024 Insights: The Global TRUST-II Study - Efficacy & Safety of Taletrectinib in Patients With ROS1+ NSCLC
By
Insights from 2024 WCLC
FEATURING
Geoffrey Liu
By
Insights from 2024 WCLC
FEATURING
Geoffrey Liu
14 views
October 11, 2024
Comments 0
Login to view comments.
Click here to Login